Artia Global Partners’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.56M | Buy |
96,479
+6,200
| +7% | +$164K | 0.62% | 18 |
|
|
2025
Q1 | $2.18M | Hold |
90,279
| – | – | 0.55% | 19 |
|
|
2024
Q4 | $3.63M | Sell |
90,279
-442,600
| -83% | -$17.8M | 1.3% | 17 |
|
|
2024
Q3 | $33.7M | Buy |
532,879
+79,900
| +18% | +$5.06M | 9.2% | 3 |
|
|
2024
Q2 | $24M | Buy |
452,979
+19,399
| +4% | +$1.03M | 4.64% | 4 |
|
|
2024
Q1 | $35.6M | Buy |
433,580
+50,000
| +13% | +$4.1M | 7.15% | 4 |
|
|
2023
Q4 | $7.14M | Hold |
383,580
| – | – | 2.08% | 7 |
|
|
2023
Q3 | $4.25M | Hold |
383,580
| – | – | 1.77% | 15 |
|
|
2023
Q2 | $6.22M | Buy |
383,580
+315,172
| +461% | +$5.11M | 2.14% | 19 |
|
|
2023
Q1 | $1.14M | Sell |
68,408
-62,505
| -48% | -$1.04M | 0.42% | 24 |
|
|
2022
Q4 | $1.23M | Buy |
+130,913
| New | +$1.23M | 0.47% | 20 |
|